KRISHNAMOHAN NEHA (Chief Financial Officer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/6/2023ACC: 0001209191-23-048429
Officer· Chief Financial Officer
Since Jun 2021
-1.46K
Net shares
Net seller
$3.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.46K
Price / share
$2.35
Trade value
$3.43K
% of position
2.1%
9/1/2023
68.51K→67.05K
Total
Net shares
−1.46K
Net value
-$3.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2023 | F · Tax Withholding | −1.46K | $2.35 | $3.43K | 2.1% | 68.51K | 67.05K |
| Total | −1.46K | -$3.43K | ||||||
Derivative Transactions0
No derivative transactions reported